Skip to main content
Clinical Trials/IRCT20140903019036N3
IRCT20140903019036N3
Recruiting
Phase 2

Comparison of efficacy and adverse effects of two chemotherapy regimens including carboplatin-paclitaxel and capecitabine-oxaliplatin in neo-adjuvant chemo-radiation of esophageal cancer for patients who were referred to Imam Khomeini cancer institute during year 95-96

Tehran University of Medical Sciences0 sites92 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
92
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Tumor should located in thoracic esophagus or gastro\-esophageal junction.
  • Patients' age should be between 18\-75 years old.
  • Pathology consists of squamous cell carcinoma or adenocarcinoma.
  • Tumor should be resectable.
  • Disease should be curable.

Exclusion Criteria

  • Patient who suffers from bad performance status.

Outcomes

Primary Outcomes

Not specified

Similar Trials